Pradip Jadav

Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridines

Rajesh Bahekar, Mukul R. Jain, Pradip Jadav et al. · Bioorganic & Medicinal Chemistry · 2007 · 90 citations

Medicinal Chemistry, Medicine, Antidiabetic Activity +5

Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines

Rajesh Bahekar, Mukul R. Jain, Ashish Goel et al. · Bioorganic & Medicinal Chemistry · 2007 · 68 citations

Bioorganic Chemistry, Medicine, Biological Evaluation +5

Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors

Dipam Patel, Mukul R. Jain, Shailesh R. Shah et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 43 citations · Full text

Medicinal Chemistry, Bioavailable Triaryl-sulfonamide, Pharmaceutical Science +12

Synthesis and Antidiabetic Activity of 3,6,7‐Trisubstituted‐2‐(1<i>H</i>‐imidazol‐2‐ylsulfanyl)quinoxalines and Quinoxalin‐2‐yl isothioureas

Rajesh Bahekar, Mukul R. Jain, Arun A. Gupta et al. · Archiv der Pharmazie · 2007 · 36 citations

Long-acting peptidomimetics based DPP-IV inhibitors

Pradip Jadav, Rajesh Bahekar, Shailesh R. Shah et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 27 citations · Full text

Medicinal Chemistry, Dpp-iv Inhibitors, Medicine +5